Clinical trial
Craving, Binge Eating and Obesity
NCT00414167 · Yale University, Other · Completed
Key facts
| NCT number | NCT00414167 |
|---|---|
| Title | Craving, Binge Eating and Obesity |
| Official title | Placebo-Controlled Trial of Bupropion for the Treatment of Binge Eating Disorder |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Binge Eating Disorder, Obesity |
| Intervention type | Drug, Other |
| Interventions | bupropion, Placebo |
| Enrollment | 61 |
| Start date | Dec 1, 2005 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Dec 21, 2006 |
| Last update posted | Apr 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: